Mometasone furoate 1 MG/ML Topical Cream — RxCUI 311753
RxNorm drug concept · Semantic clinical drug
RxCUI 311753
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311753
Official nameMometasone furoate 1 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmometasone furoate 0.1 % Topical Cream
FDA products mapped13
Package NDCs mapped18
Reported Medicaid activity (SDUD)212,025 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Mometasone Nasal Spray: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You might start to notice some relief within 12 hours of your first dose, but the full effect usually kicks in after several days of using it regularly, once a day. It works best w...
- How long does it take for this spray to start working?
- Yes, it's designed for daily use, and for most people it's well tolerated over the long term at the recommended dose. That said, your doctor should check your nasal passages period...
- Is it okay to use this spray every day long-term?
🕸️ Concept Web — How Mometasone furoate 1 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Mometasone furoate 1 MG/ML Topical Cream
RxCUI 311753 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Mometasone
108118IN -
Mometasone furoate
30145PIN
-
Mometasone
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mometasone Topical Cream
619083SCDF -
Mometasone furoate Topical Cream
2648255SCDFP -
Mometasone Topical Product
1165393SCDG -
Mometasone furoate Topical Product
2661871SCDGP -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Mometasone Topical Cream
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mometasone furoate 1 MG/ML
358650SCDC
-
Mometasone furoate 1 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mometasone furoate 1 MG/ML
SCDC · 358650 -
Mometasone Topical Cream
SCDF · 619083 -
Mometasone furoate Topical Cream
SCDFP · 2648255 -
Mometasone Topical Product
SCDG · 1165393 -
Mometasone furoate Topical Product
SCDGP · 2661871
📦 FDA Products & Package NDCs
13 products · 18 package NDCs
18 package NDCs map to RxCUI 311753 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00713-0634-15 | 1 TUBE in 1 CARTON (0713-0634-15) / 15 g in 1 TUBE | Mometasone Furoate | Cosette Pharmaceuticals, Inc. | 2006-08-23 |
| 00713-0634-37 | 1 TUBE in 1 CARTON (0713-0634-37) / 45 g in 1 TUBE | Mometasone Furoate | Cosette Pharmaceuticals, Inc. | 2006-08-23 |
| 45802-0257-35 | 1 TUBE in 1 CARTON (45802-257-35) / 15 g in 1 TUBE | Mometasone Furoate | Padagis Israel Pharmaceuticals Ltd | 2024-04-05 |
| 45802-0257-42 | 1 TUBE in 1 CARTON (45802-257-42) / 45 g in 1 TUBE | Mometasone Furoate | Padagis Israel Pharmaceuticals Ltd | 2024-04-05 |
| 50090-2991-00 | 1 TUBE in 1 CARTON (50090-2991-0) / 45 g in 1 TUBE | Mometasone Furoate | A-S Medication Solutions | 2017-04-28 |
| 51672-1315-01 | 1 TUBE in 1 CARTON (51672-1315-1) / 15 g in 1 TUBE | Mometasone Furoate | Sun Pharmaceutical Industries, Inc. | 2004-12-21 |
| 51672-1315-06 | 1 TUBE in 1 CARTON (51672-1315-6) / 45 g in 1 TUBE | Mometasone Furoate | Sun Pharmaceutical Industries, Inc. | 2004-12-21 |
| 63187-0288-15 | 15 g in 1 TUBE (63187-288-15) | Mometasone Furoate | Proficient Rx LP | 2019-01-01 |
| 63187-0432-15 | 15 g in 1 TUBE (63187-432-15) | Mometasone Furoate | Proficient Rx LP | 2019-01-01 |
| 63629-8681-01 | 1 TUBE in 1 CARTON (63629-8681-1) / 15 g in 1 TUBE | Mometasone Furoate | Bryant Ranch Prepack | 2024-04-05 |
| 63629-8682-01 | 1 TUBE in 1 CARTON (63629-8682-1) / 45 g in 1 TUBE | Mometasone Furoate | Bryant Ranch Prepack | 2021-07-21 |
| 68462-0192-17 | 15 g in 1 TUBE (68462-192-17) | Mometasone Furoate | Glenmark Pharmaceuticals Inc., USA | 2008-05-28 |
| 68462-0192-55 | 45 g in 1 TUBE (68462-192-55) | Mometasone Furoate | Glenmark Pharmaceuticals Inc., USA | 2008-05-28 |
| 68788-4075-04 | 1 TUBE in 1 CARTON (68788-4075-4) / 45 g in 1 TUBE | Mometasone Furoate | Preferred Pharmaceuticals Inc. | 2026-01-27 |
| 68788-8548-04 | 1 TUBE in 1 CARTON (68788-8548-4) / 45 g in 1 TUBE | Mometasone Furoate | Preferred Pharmaceuticals Inc. | 2023-11-14 |
| 71335-2873-01 | 1 TUBE in 1 CARTON (71335-2873-1) / 15 g in 1 TUBE | Mometasone Furoate | Bryant Ranch Prepack | 2025-10-24 |
| 72162-1404-02 | 1 TUBE in 1 CARTON (72162-1404-2) / 15 g in 1 TUBE | Mometasone Furoate | Bryant Ranch Prepack | 2024-04-05 |
| 72162-1404-04 | 1 TUBE in 1 CARTON (72162-1404-4) / 45 g in 1 TUBE | Mometasone Furoate | Bryant Ranch Prepack | 2024-04-05 |
Observed labelers:
Bryant Ranch Prepack (5) ·
Cosette Pharmaceuticals, Inc. (2) ·
Glenmark Pharmaceuticals Inc., USA (2) ·
Padagis Israel Pharmaceuticals Ltd (2) ·
Preferred Pharmaceuticals Inc. (2) ·
Proficient Rx LP (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.3543
Range $0.2881–$0.4206
· middle 50% $0.2881–$0.4206
· 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.